UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 199

Sortiert nach

High Cefepime Plasma Concentrations and Neurological Toxicity in Febrile Neutropenic Patients with Mild Impairment of Renal Function

Antimicrobial Agents and Chemotherapy, 2010-10, Vol.54 (10), p.4360-4367

2010

Volltextzugriff (PDF)

Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2009-07, Vol.877 (22), p.1982-1996

2009

Volltextzugriff (PDF)

A single LC–tandem mass spectrometry method for the simultaneous determination of 14 antimalarial drugs and their metabolites in human plasma

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2009-04, Vol.877 (10), p.867-886

2009

Volltextzugriff (PDF)

A LC–tandem MS assay for the simultaneous measurement of new antiretroviral agents: Raltegravir, maraviroc, darunavir, and etravirine

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2009-04, Vol.877 (11), p.1057-1069

2009

Volltextzugriff (PDF)

Clinical usefulness of therapeutic concentration monitoring for imatinib dosage individualization: results from a randomized controlled trial

Cancer chemotherapy and pharmacology, 2014-12, Vol.74 (6), p.1307-1319

2014

Volltextzugriff (PDF)

Pharmacogenetics-Based Population Pharmacokinetic Analysis of Efavirenz in HIV-1-Infected Individuals

Clinical pharmacology and therapeutics, 2009-05, Vol.85 (5), p.485-494

2009

Volltextzugriff (PDF)

Stable HIV‐1 reservoirs on dolutegravir maintenance monotherapy: the MONODO study

HIV medicine, 2018-09, Vol.19 (8), p.572-577

2018

Volltextzugriff (PDF)

Intracellular measurements of anti-HIV drugs indinavir, amprenavir, saquinavir, ritonavir, nelfinavir, lopinavir, atazanavir, efavirenz and nevirapine in peripheral blood mononuclear cells by liquid chromatography coupled to tandem mass spectrometry

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2005-05, Vol.819 (2), p.259-276

2005

Volltextzugriff (PDF)

Population pharmacokinetics of imatinib and the role of α1‐acid glycoprotein

British journal of clinical pharmacology, 2006-07, Vol.62 (1), p.97-112

2006

Volltextzugriff (PDF)

A simple, robust and rapid approach to detect carbapenemases in Gram-negative isolates by MALDI-TOF mass spectrometry: validation with triple quadripole tandem mass spectrometry, microarray and PCR

Clinical microbiology and infection, 2014-12, Vol.20 (12), p.O1106-O1112

2014

Volltextzugriff (PDF)

Relationship of imatinib-free plasma levels and target genotype with efficacy and tolerability

British journal of cancer, 2008-05, Vol.98 (10), p.1633-1640

2008

Volltextzugriff (PDF)

Population Pharmacokinetics of Ganciclovir in Solid-Organ Transplant Recipients Receiving Oral Valganciclovir

Antimicrobial Agents and Chemotherapy, 2009-07, Vol.53 (7), p.3017-3023

2009

Volltextzugriff (PDF)

An ultra performance liquid chromatography–tandem MS assay for tamoxifen metabolites profiling in plasma: First evidence of 4′-hydroxylated metabolites in breast cancer patients

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2010-12, Vol.878 (32), p.3402-3414

2010

Volltextzugriff (PDF)

Imatinib plasma levels: correlation with clinical benefit in GIST patients

British journal of cancer, 2010-03, Vol.102 (7), p.1198-1199

2010

Volltextzugriff (PDF)

Determination of imatinib (Gleevec ®) in human plasma by solid-phase extraction–liquid chromatography–ultraviolet absorbance detection

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2004-04, Vol.803 (2), p.285-292

2004

Volltextzugriff (PDF)

Determination of aciclovir and ganciclovir in human plasma by liquid chromatography–spectrofluorimetric detection and stability studies in blood samples

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2007-06, Vol.852 (1), p.420-429

2007

Volltextzugriff (PDF)

Pharmacokinetics and Dosage Adaptation of Meropenem during Continuous Venovenous Hemodiafiltration in Critically Ill Patients

Journal of clinical pharmacology, 2003-12, Vol.43 (12), p.1329-1340

2003

Volltextzugriff (PDF)

Validation and clinical application of a multiplex high performance liquid chromatography – tandem mass spectrometry assay for the monitoring of plasma concentrations of 12 antibiotics in patients with severe bacterial infections

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2020-11, Vol.1157, p.122160, Article 122160

2020

Volltextzugriff (PDF)

Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extraction

Journal of chromatography. B, Biomedical sciences and applications, 2000-03, Vol.740 (1), p.43-58

2000

Volltextzugriff (PDF)

Liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) methods for the therapeutic drug monitoring of cytotoxic anticancer drugs: An update

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2024-04, Vol.1236, p.124039-124039, Article 124039

2024

Volltextzugriff (PDF)

Isavuconazole brain penetration in cerebral aspergillosis

Journal of antimicrobial chemotherapy, 2019-06, Vol.74 (6), p.1751-1753

2019

Volltextzugriff (PDF)

Diet acids and alkalis influence calcium retention in bone

Osteoporosis international, 2001-01, Vol.12 (6), p.493-499

2001

Volltextzugriff (PDF)

Determination of the novel non-peptidic HIV-protease inhibitor tipranavir by HPLC–UV after solid-phase extraction

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2006-02, Vol.832 (1), p.138-143

2006

Volltextzugriff (PDF)

Determination of the new HIV-protease inhibitor atazanavir by liquid chromatography after solid-phase extraction

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2004-10, Vol.810 (1), p.25-34

2004

Volltextzugriff (PDF)

A battery of tandem mass spectrometry assays with stable isotope-dilution for the quantification of 15 anti-tuberculosis drugs and two metabolites in patients with susceptible-, multidrug-resistant- and extensively drug-resistant tuberculosis

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2022-11, Vol.1211, p.123456-123456, Article 123456

2022

Volltextzugriff (PDF)

1 – 25 von 199

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(173)
Mit Volltextzugriff
(176)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(120)
Life Sciences & Biomedicine
(111)
Humans
(100)
Biological And Medical Sciences
(82)
Medical Sciences
(78)
Pharmacology. Drug Treatments
(64)
Male
(62)
Female
(53)
Adult
(49)
Pharmacology & Pharmacy
(44)
Middle Aged
(41)
Infectious Diseases
(35)
Chemistry
(31)
Physical Sciences
(31)
Hiv Infections - Drug Therapy
(29)
Chemistry, Analytical
(25)
General Pharmacology
(25)
Aged
(24)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(22)
Microbiology
(22)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

High Cefepime Plasma Concentrations and Neurological Toxicity in Febrile Neutropenic Patients with Mild Impairment of Renal Function

Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry

A single LC–tandem mass spectrometry method for the simultaneous determination of 14 antimalarial drugs and their metabolites in human plasma

A LC–tandem MS assay for the simultaneous measurement of new antiretroviral agents: Raltegravir, maraviroc, darunavir, and etravirine

Clinical usefulness of therapeutic concentration monitoring for imatinib dosage individualization: results from a randomized controlled trial

Pharmacogenetics-Based Population Pharmacokinetic Analysis of Efavirenz in HIV-1-Infected Individuals

Stable HIV‐1 reservoirs on dolutegravir maintenance monotherapy: the MONODO study

Intracellular measurements of anti-HIV drugs indinavir, amprenavir, saquinavir, ritonavir, nelfinavir, lopinavir, atazanavir, efavirenz and nevirapine in peripheral blood mononuclear cells by liquid chromatography coupled to tandem mass spectrometry

Population pharmacokinetics of imatinib and the role of α1‐acid glycoprotein

A simple, robust and rapid approach to detect carbapenemases in Gram-negative isolates by MALDI-TOF mass spectrometry: validation with triple quadripole tandem mass spectrometry, microarray and PCR

Relationship of imatinib-free plasma levels and target genotype with efficacy and tolerability

Population Pharmacokinetics of Ganciclovir in Solid-Organ Transplant Recipients Receiving Oral Valganciclovir

An ultra performance liquid chromatography–tandem MS assay for tamoxifen metabolites profiling in plasma: First evidence of 4′-hydroxylated metabolites in breast cancer patients

Imatinib plasma levels: correlation with clinical benefit in GIST patients

Determination of imatinib (Gleevec ®) in human plasma by solid-phase extraction–liquid chromatography–ultraviolet absorbance detection

Determination of aciclovir and ganciclovir in human plasma by liquid chromatography–spectrofluorimetric detection and stability studies in blood samples

Pharmacokinetics and Dosage Adaptation of Meropenem during Continuous Venovenous Hemodiafiltration in Critically Ill Patients

Validation and clinical application of a multiplex high performance liquid chromatography – tandem mass spectrometry assay for the monitoring of plasma concentrations of 12 antibiotics in patients with severe bacterial infections

Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extraction

Liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) methods for the therapeutic drug monitoring of cytotoxic anticancer drugs: An update

Isavuconazole brain penetration in cerebral aspergillosis

Diet acids and alkalis influence calcium retention in bone

Determination of the novel non-peptidic HIV-protease inhibitor tipranavir by HPLC–UV after solid-phase extraction

Determination of the new HIV-protease inhibitor atazanavir by liquid chromatography after solid-phase extraction

A battery of tandem mass spectrometry assays with stable isotope-dilution for the quantification of 15 anti-tuberculosis drugs and two metabolites in patients with susceptible-, multidrug-resistant- and extensively drug-resistant tuberculosis

Suchergebnisse filtern